Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Diabetic Gastroparesis

NCT05832151 is registered in ClinicalTrials.gov with CinDome Pharma, Inc. as lead sponsor.

NCT NCT05832151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Diabetic Gastroparesis
Lead sponsor
CinDome Pharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 27, 2023
Completion date
December 12, 2025
Enrollment
382 (actual)
Sites
100

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic gastroparesis